Home » Newsletters » BioWorld Science

BioWorld Science

Jan. 31, 1997

View Archived Issues

Serine protease inhibitors reported by Akzo Nobel

Astra investigates H. pylori vaccines

Takeda researches follow-up compounds to leuprorelin

New MMP inhibitors reported by Warner-Lambert

New NNRTI described for combination therapy

New anticoagulant drug candidates from Berlex

DuPont Merck reports new fibrinogen antagonists

CP-0840: Dual-action bradykinin antagonist/mu-opioid agonist from Cortech

Shaman describes antidiabetic agents from natural source

Novel antiinfective agents from Tanabe

Potent antitumor agents from Takeda

U.K. biotechnology company offers late-stage vaccine for licensing

NCI discloses anti-HIV agent with novel mechanism of action

Abbott develops protease inhibitor for combination therapy

Cel-Sci presents results with heteroconjugate technology for HIV vaccine development

Genotypic analysis of patients treated with adefovir dipivoxil

Micrologix receives broad patent coverage for peptide antibiotic production method

Preclinical results support Pharmadigm's DHEA development program

Sequus and Protein Sciences collaborate on production and development of HIV Rx

New use reported for a known veterinary anticoccidial agent

Biotech launches Diab II

Sepracor granted U.S. patent for Claritin metabolite

FDA approves antidiabetic drug within 6 months of filing

Iceland moss component displays anti-H. pylori activity in vitro

Teva generic approved

Novel formulation of aciclovir enters pivotal trials

FDA approves Teva drug

SKB acellular DTP vaccine approved in U.S.

Chiron/Baxter collaboration for novel cell therapy product for leukemia

Zeneca/Pharmacopeia collaboration signed

Popular Stories

Today's news in brief
BioWorld
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
Astellas’ ASP-2246 shows promise in stroke management
BioWorld Science
Astellas Pharma Inc. recently presented data regarding ASP-2246, a drug candidate comprised of an mRNA encoding the transcription factor NeuroD1 encapsulated in...